Editor Conflict of Interest Disclosures

Consulting or Advisory Role: Bristol Myers Squibb, Immatics, Instil Bio, Iovance, Lyell Immunopharma, Novartis, and Pfizer

Research funding: Iovance

Honoraria: Advanced Accelerator Applications, Astellas Colombia, Astellas Scientific and Medical Affairs Inc, AstraZeneca, Bayer, Clovis Oncology, Exelixis, Genentech, Janssen, Merck, Myovant Sciences, Pfizer, Sanofi, and Telix Pharmaceuticals

Consulting or Advisory Role: Advanced Accelerator Applications, Astellas Pharma, AstraZeneca, Bayer, Blue Earth Diagnostics, Exelixis, Janssen, Lantheus Medical Imaging, Merck, Myovant Sciences, Myriad Genetics, Novartis, and Sanofi

Research Funding: Astellas Scientific and Medical Affairs Inc, AstraZeneca, Bayer, Dendreon, Genentech, Myovant Sciences, Sanofi, and Seattle Genetics/Astellas

Travel, Accommodations, Expenses: Sanofi and Telix Pharmaceuticals

Stock and Other Ownership Interests: Bactonix 

Honoraria: Bristol-Myers Squibb, Immunocore, Novartis, Pfizer, and Regeneron 

Consulting or Advisory Role: Alkermes, Amgen, Bactonix, BeiGene, BioAtla, Bristol-Myers Squibb, Esai Biotech, Genentech, Georgiamune, GigaGen, GlaxoSmithKline, Grit Biotechnology, Idera, Immunocore, Incyte, Instil Bio, IO Biotech, Iovance, Janssen, KSQ Therapeutics, Merck, Moderna Therapeutics, NGM Biopharmaceuticals, Novartis, Obsidian Therapeutics, Pfizer, Regeneron, Roche, Sanofi, Seattle Genetics, Tempus, Vial, and Zelluna

Speakers' Bureau: Bristol-Myers Squibb, Immunocore, Novartis, Pfizer, and Regeneron

Research Funding: Aduro Biotech, Akeso Biopharma, Amgen, Arcus Biosciences, Bioatla, Bristol-Myers Squibb, CytomX Therapeutics, Exelixis, Genentech, GlaxoSmithKline, Idera, Immunocore, Incyte, Iovance Biotherapeutics, Merck, Merck Serono, Moderna Therapeutics, NextCure, Novartis, Pfizer, Regeneron, Roche, Sanofi, Seattle Genetics, Torque, and Zelluna

No conflicts to report

Consulting or Advisory Role: Seattle Genetics

Consulting or Advisory Role: Bristol-Myers Squibb, AstraZeneca, MSD Oncology

Speakers' Bureau: MSD Oncology, Bristol-Myers Squibb

Travel, Accommodations, Expenses: Bristol-Myers Squibb, Pfizer

No conflicts to report

Honoraria: Roche, Novartis, Pfizer, MSD Oncology, Lilly

Research Funding: Roche

Travel, Accommodations, Expenses: Celgene, MSD Oncology, Roche, Novartis

No conflicts to report

No conflicts to report

Consulting or Advisory Role: AstraZeneca, Amgen, Boehringer Ingelheim

Speakers' Bureau: Roche

Leadership: IBA - Ion Beam Applications

Consulting or Advisory Role: IBA

Travel, Accommodations, Expenses: IBA

No conflicts to report

No conflicts to report

No conflicts to report

Honoraria: Bayer, Bristol-Myers Squibb, Fresenius Kabi, Roche, Pfizer

Consulting or Advisory Role: Bayer, Pfizer

Speakers' Bureau: Bayer, Daiichi Sankyo

Travel, Accommodations, Expenses: Pfizer

Research Funding: Astellas Pharma, Chimerix, and Merck

Consulting or Advisory Role: Genomic Health

Travel, Accommodations, Expenses: TEVA, Tel Aviv

No conflicts to report

No conflicts to report

No conflicts to report

No conflicts to report as of 7/13/18

Employment: UpToDate

Patents, Royalties, & Other Intellectual Property: UpToDate, Royalties from Oxford Textbook of Cancer Communication, co-editor

Travel, Accommodations, Expenses: GEOMC, Inc. Seoul, Korea

Consulting or Advisory Role: 3M, BlueCross and BlueShield of Michigan, Amgen

Honoraria: Genomic Health, Eisai, Genentech/Roche, Celgene

Consulting or Advisory Role: Genentech/Roche, Pfizer, Celgene, Eisai

Speakers' Bureau: Genomic Health, Eisai, Genentech/Roche, Celgene

Research Funding: Bayer

Travel, Accommodations, Expenses: Genomic Health, Genentech/Roche, Eisai, Celgene

Honoraria: Pfizer, Amgen, Bristol-Myers Squibb, Tesaro

Consulting or Advisory Role: Amgen, Bristol-Myers Squibb, Pfizer, Helsinn Therapeutics

Speakers' Bureau: Genentech/Roche

Research Funding: Helsinn Therapeutics

Institutional Research Funding: AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Genentech/Roche, Lilly, Merck, and Pfizer

Research Funding: Eisai, Pfizer

Stock & Other Ownership Interests: AuraSense LLC, Nanosphere Inc.

Honoraria: Celgene, Pharmacyclics, Janssen Biotech, Valeant Pharmaceuticals International

Consulting or Advisory Role: Celgene, Genetech Health Practices Consulting, Seattle Genetics

Research Funding: Celgene, Lilly

Consulting or Advisory Role: Gerson Lehrman Group, Caris Life Sciences

Consulting or Advisory Role: Boehringer Ingelheim

Research Funding: Boehringer Ingelheim, AstraZeneca, Exelixis, Novartis, MedImmune, Merck, Genentech/Roche, Lilly, Bayer

No conflicts to report

Honoraria: Advaxis

Consulting or Advisory Role: Merck, NextCure, and Novartis

Research Funding: Fujifilm, Immunogen, Leap Therapeutics, Merck, Mersana, Novartis, SQZ Biotechnologies, Syndax, and Tesaro

Travel, Accommodations, Other Expenses: AstraZeneca

Consulting/Advisory Board: AstraZeneca

Advisory Board: Novocure, Guardant Health, Takeda

Consulting or Advisory Role: Magellan Health

Leadership: Cellworks, LifeLink

Consulting or Advisory Role: Integra

No conflicts to report

Consulting or Advisory Role: BMS, HUTCHMED, Ipsen, Isotope Technologies Munich SE (ITM), and Novartis (Advanced Accelerator Applications)

Research Funding: Novartis (Advanced Accelerator Applications) and RayzeBio